00660.HK
Wai Chun Bio-Technology Limited
HKSE · Basic Materials · Chemicals · HK
HKD 0.43
+0.00%Year over year
Reported trailing growth
- Revenue
- +66.7%
- EBITDA
- -19.7%
- EBIT
- +167.2%
- EPS
- +87.1%
- Free cash flow
- —
- Operating cash flow
- -14.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.8%
- EBITDA
- -18.1%
- EBIT
- -15.5%
- Net income
- +52.8%
- EPS
- +54.1%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025